Our recent research demonstrates that aerobic exercise (AE) serves as a potent non-pharmacological intervention to mitigate these pathologies through the activation of β2-adrenergic receptor (β2-AR) signaling, which in turn rectifies autophagy-lysosomal flux via distinct molecular mechanisms in Aβ- and tau-driven AD models. The gene discussed is MAPT; the disease is Alzheimer disease.